Amniotic Membrane Market By Product (Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane) By Application (Surgical Wound, Ophthalmology) By Crop Type (Hospitals, Ambulatory Surgical Centers, Specialized) and Region - Global Forecast to 2027
14th August 2018
The global amniotic membrane market is estimated to value of over US$ 0.9 Bn in 2017, and is projected to register a CAGR of 9.2% in terms of value during the forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global amniotic membrane market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market. The Amniotic Membrane market report offers insightful and detailed information regarding the various key players operating in the global amniotic membrane market, their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint. The global amniotic membrane market is segmented on the basis of product, application, end user, and region.
Amniotic membrane is the thin tissue that creates the walls of the amniotic sac. It is the innermost layer of placenta consisting of a thick basement membrane and an avascular stromal matrix. It can be used as a graft or as a dressing to facilitate ocular surface reconstruction and to promote healing.
Global Amniotic Membrane Market Dynamics:
Major factors driving growth of the global amniotic membrane market are increasing adoption of amniotic membrane for performing various ophthalmic and other surgeries due to its durability, hypoallergenic, anti-inflammatory and anti-scarring properties. In addition, amniotic membrane grafts can reduce Pterygium recurrence, which is expected to help show reliance on amniotic membrane, and thus increase its adoption for surgeries.
Increasing usage of amniotic membrane in injections and medicines for treating musculoskeletal diseases or disorders is expected to further increase demand and revenue growth of the market.
Increasing therapeutic treatments such as Platelet Rich Plasma Therapy (PRP), especially to treat sports injuries and athletes for faster healing process. PRP therapy can be used to treat injured tendons, ligaments, or joints, and could help heal the patient quicker. It is commonly used to treat osteoarthritis of knee, shoulder, hip and spine, rotator cuff tears, ACL injuries, back and neck injuries, tennis elbow, tendonitis, ligament sprains, and various others. These are among the major factors expected to drive demand for amniotic derived products over the forecast period.
However, growing demand for open surgeries is expected to decrease rapidly owing to rising preference for minimally invasive surgeries that are possible using lasers and robotic technology and in turn expected to restrain revenue growth of the global amniotic membrane market over the forecast period.
Analysis by Product:
On the basis of product segmentation, the cryopreserved amniotic membrane segment is expected to contribute major revenue share to the global market and is expected to maintain its dominance over the forecast period. The fungicide segment witnesses a CAGR over 9.0%. Cryopreserved amniotic membranes help to treat various corneal, epithelial, and conjunctival disorders, including neurotrophic ulcers, persistent epithelial defects, microbial keratitis, band keratopathy, and chemical burns. It is also used to speed up wound healing and promote regeneration of stem cells in unhealthy corneas, as well as to prevent scarring after a variety of procedures, which are major factors expected to support growth of the cryopreserved amniotic membrane segment in the global amniotic membrane market in the near future.
Analysis by Application:
Among all the application segments, the surgical wound segment accounts for highest share in terms of revenue in the global market. The liquid segment is projected to register a CAGR over 8% during the forecast period. Manufacturers are focusing on getting FDA approvals as amniotic membranes used to treat human surgical wounds need to be FDA approved, which is another factor expected to support growth of this segment over the forecast period.
Analysis by End User:
Among all the end user segments, the hospitals segment accounted for highest revenue share in terms of revenue in 2017 in the global market. The segment growth is attributed to increasing number of amniotic membrane transplants and rising awareness about the benefits and advantages of amniotic membrane transplants among the patient pool.
Ambulatory Surgery Centers (ASCs) are also called same day surgery centers, outpatient surgery centers, or surgicenters, and are health care facilities where surgeries are performed efficiently and do not require hospital stay, as well as are also comparatively less complicated. Ambulatory surgical centers segment is expected to witness a higher revenue growth rate over the forecast period attributable to various advantages such as faster recovery post treatment, less time as hospital stay etc.
Analysis by Region:
Growth of the amniotic membrane market in North America is attributed to rising demand for amniotic membrane from end users such as hospitals, ambulatory surgical centers, and specialty clinics. Amniotic membrane is used as a graft or as a dressing in different surgical subspecialties; whereas, in ophthalmology, amniotic membrane is used as a tissue bandage for cornea infections and sterile malts.
The Europe market accounted for major share in terms of revenue in the global amniotic membrane market in 2017. The market in Europe is expected to witness considerable growth in terms of revenue during the forecast period. Increasing demand for amniotic membrane for ophthalmology to treat various types of ocular disorders in countries in the region is a major factor expected to propel growth of the market in the region over the forecast period. Furthermore, presence of prominent international players in the market such as Applied Biological Laboratories Inc., Tissuetech Inc., Amniox Medical, Inc., and others in the region are other factors expected to fuel growth of the Europe amniotic membrane market.
The Asia Pacific market accounts for significant share in terms of revenue in the global market. The Asia Pacific amniotic membrane market is expected to witness highest growth in terms of revenue and is expected to register a CAGR of over 9% during the forecast period. Increasing adoption of amniotic membrane in applications such as surgical wounds healing and ophthalmology in countries in the region due to specific properties such as anti-scarring and anti-adhesive activity, non-immunogenic and low antigenicity, anti-microbial and analgesic effects, and anti-inflammatory effects are factors expected to drive growth of the target market over the forecast period.
The market in Latin America accounts for over 6% of revenue share in the global market in 2017. Increasing awareness about benefits and advantages of advanced treatment therapies using amniotic membrane in countries in the region is a major factor expected to bolster growth of the Latin America market to a significant extent. Increasing government initiatives and investments into development of medical infrastructure is also expected to propel growth of the market to a significant extent in the near future.
Global Amniotic Membrane Market segmentation:
Segmentation on the basis of product:
- Cryopreserved Amniotic Membrane
- Lyophilization Amniotic Membrane
Segmentation on the basis of application:
- Surgical Wound
- Others (diagnostic applications, reconstructive urology, etc.)
Segmentation on the basis of crop type:
- Ambulatory Surgical Centers
- Specialized Clinics
- Research Centers and Laboratory
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- Tissuetech, Inc.
- Integra LifeSciences Holdings Corporation (Derma Sciences Inc.)
- Alliqua BioMedical, Inc. (Celularity, Inc.)
- Skye Biologics, Inc.
- Human Regenerative Technologies, LLC
- MiMedx Group, Inc.
- Amnio Technology, LLC
- Katena Products Inc.
1.0 Chapter 1
- 1.1 Preface
- 1.2 Assumptions
- 1.3 Abbreviations
- 2.1 Report Description
- 2.1.1 Market Definition and Scope
- 2.2 Executive Summary
- 2.2.1 Market Snapshot, By Product
- 2.2.2 Market Snapshot, By Application
- 2.2.3 Market Snapshot, By End User
- 2.2.4 Market Snapshot, By Region
- 2.2.5 Prudour Opportunity Map Analysis
Don't just take our word. We are trusted by these great companies!